• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Avatrombopag Maleate
BioHub® Magnetic Separator
Avatrombopag
Ursodeoxycholic acid
Troxerutin
CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

Venezuela receives first shipment of Cuban coronavirus vaccine

firstwordpharmaJune 25, 2021

Tag: Venezuela , Cuban coronavirus , Vaccine

Venezuela’s vice president Delcy Rodriguez said the country received its first shipment of doses of Cuba's Abdala COVID-19 vaccine on Thursday, as reported in This is Money.

Venezuela receives first shipment of Cuban coronavirus vaccine

Authorities did not specify how many doses had arrived, but said that Venezuela had signed a contract to purchase 12 million doses of the vaccine. 

Earlier this week, Cuba said that the three-shot Abdala vaccine had proved 92.28% effective in last-stage clinical trials.

Since February, Venezuela has received some 3.5 million doses of Russian and Chinese vaccines for its population of approximately 28 million. 


Previous:OncoSec Appoints Brian Leuthner as Interim CEO

Next:Hospital Factors Tied to Greater COVID-19 Mortality in Blacks

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Venezuela receives first shipment of Cuban coronavirus vaccine | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

Poliomyelitis Vaccine (Vero Cell), Inactivated, Sabin Strains

Poliomyelitis Vaccine (Vero Cell), Inactivated, Sabin Strains
Intranasal spray device, 100mcl, for vaccine delivery

Intranasal spray device, 100mcl, for vaccine delivery
Influenza A (H1N1) Vaccine, (Split, Inactivated)by Hualan biological

Influenza A (H1N1) Vaccine, (Split, Inactivated)by Hualan biological
Quadrivalent Influenza Vaccine Hualan Bio

Quadrivalent Influenza Vaccine Hualan Bio
H7N9 Inactivated Influenza Vaccine-HUALAN BIO

H7N9 Inactivated Influenza Vaccine-HUALAN BIO
Influenza Vaccine(Split Virion),Inactivated with high quality

Influenza Vaccine(Split Virion),Inactivated with high quality
Hualan Influenza Vaccine (Split virion)

Hualan Influenza Vaccine (Split virion)
Trivalent Influenza Vaccine

Trivalent Influenza Vaccine
Hualan Quadrivalent Influenza Vaccine

Hualan Quadrivalent Influenza Vaccine
Meningococcal Group A&C Polysaccharide Conjugate Vaccine

Meningococcal Group A&C Polysaccharide Conjugate Vaccine

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service